Novo Nordisk cited concerns about Hims & Hers selling and promoting knockoff compounded GLP-1 drugs, which are more affordable versions of the popular weight loss medications
The information below describes the dosing approach used in the Phase 2 clinical trial (Jastreboff et al., NEJM 2023) for context only
Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes
A multidisciplinary expert consensus published in The Journal of Clinical Medicine reports that gastrointestinal (GI) adverse events affect 4070% of GLP-1 users, with nausea being the most common complaint, particularly during dose escalation
Once reconstituted, store refrigerated and use within appropriate timeframes
Consultation, medication, dose escalation, and shipping should be bundled